Anand S. Dutta

825 total citations
38 papers, 564 citations indexed

About

Anand S. Dutta is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anand S. Dutta has authored 38 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anand S. Dutta's work include Chemical Synthesis and Analysis (17 papers), Neuropeptides and Animal Physiology (6 papers) and Peptidase Inhibition and Analysis (5 papers). Anand S. Dutta is often cited by papers focused on Chemical Synthesis and Analysis (17 papers), Neuropeptides and Animal Physiology (6 papers) and Peptidase Inhibition and Analysis (5 papers). Anand S. Dutta collaborates with scholars based in United Kingdom, Brazil and India. Anand S. Dutta's co-authors include Michael B. Giles, James J. Gormley, J. S. Morley, B. Valcaccia, B.J.A. Furr, Alec J. Jamieson, A. L. WALPOLE, Joseph C. Williams, J.S. Shaw and J.R. Woodburn and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Anand S. Dutta

37 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anand S. Dutta United Kingdom 15 355 174 116 90 52 38 564
Warren S. Wade United States 15 788 2.2× 246 1.4× 70 0.6× 166 1.8× 73 1.4× 24 1.1k
Ayumu Niida Japan 16 580 1.6× 293 1.7× 99 0.9× 134 1.5× 42 0.8× 27 867
A. J. Verkley Netherlands 11 372 1.0× 56 0.3× 31 0.3× 61 0.7× 53 1.0× 17 625
Theodore Lambros United States 13 711 2.0× 330 1.9× 115 1.0× 163 1.8× 97 1.9× 23 973
Manas K. Chaudhuri United States 12 621 1.7× 49 0.3× 40 0.3× 141 1.6× 155 3.0× 12 816
Francesco Chillemi Italy 16 462 1.3× 69 0.4× 41 0.4× 68 0.8× 50 1.0× 35 693
Sascha Hoogendoorn Netherlands 15 474 1.3× 243 1.4× 90 0.8× 51 0.6× 76 1.5× 32 796
Marie-Noëlle Dufour France 11 406 1.1× 247 1.4× 63 0.5× 29 0.3× 14 0.3× 16 586
Maria H. Knoppers United States 7 365 1.0× 107 0.6× 57 0.5× 19 0.2× 84 1.6× 9 477
G. D. Clarke United Kingdom 9 326 0.9× 48 0.3× 89 0.8× 63 0.7× 97 1.9× 14 596

Countries citing papers authored by Anand S. Dutta

Since Specialization
Citations

This map shows the geographic impact of Anand S. Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand S. Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand S. Dutta more than expected).

Fields of papers citing papers by Anand S. Dutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand S. Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand S. Dutta. The network helps show where Anand S. Dutta may publish in the future.

Co-authorship network of co-authors of Anand S. Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Anand S. Dutta. A scholar is included among the top collaborators of Anand S. Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand S. Dutta. Anand S. Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dutta, Anand S. & Amanda L. Garner. (2003). The pharmaceutical industry and research in 2002 and beyond. Drug News & Perspectives. 16(10). 637–637. 4 indexed citations
2.
Sarma, Akella V. S., et al.. (2002). NMR study of cyclic peptides with renin inhibitor activity. Journal of Biochemical and Biophysical Methods. 51(1). 27–45. 3 indexed citations
3.
Littlechild, J.A., et al.. (2001). Amino Acids, Peptides and Proteins. 3 indexed citations
4.
Furlong, Stephen T., Anand S. Dutta, James J. Gormley, et al.. (2000). C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl α-ketoheterocycles. Immunopharmacology. 48(2). 199–212. 31 indexed citations
5.
Dutta, Anand S., James J. Gormley, Lorraine Hassall, et al.. (2000). Potent Cyclic Monomeric and Dimeric Peptide Inhibitors of VLA-4 (?4?1 Integrin)-Mediated Cell Adhesion Based on the Ile-Leu-Asp-Val Tetrapeptide. Journal of Peptide Science. 6(7). 321–341. 7 indexed citations
6.
Dutta, Anand S., James J. Gormley, Lorraine Hassall, et al.. (2000). Potent cyclic peptide inhibitors of VLA-4 (?4?1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-d-Arg-d-Arg) (ZD7349) compatible with depot formulation. Journal of Peptide Science. 6(8). 398–412. 17 indexed citations
7.
Littlechild, J.A., et al.. (1999). Amino Acids, Peptides and Proteins. 2 indexed citations
8.
Rees, Amanda, Anand S. Dutta, James J. Gormley, et al.. (1999). Anti‐inflammatory activity of c(ILDV‐NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA‐4‐mediated cell adhesion. British Journal of Pharmacology. 126(8). 1751–1760. 31 indexed citations
9.
Jagannadh, Bulusu, et al.. (1995). NMR studies on the structure of some cyclic and linear antagonists of luteinizing hormone‐releasing hormone (LHRH). International journal of peptide & protein research. 46(1). 9–17. 15 indexed citations
10.
Dutta, Anand S., James J. Gormley, J.R. Woodburn, et al.. (1993). Antagonists of luteinising hormone-releasing hormone (LHRH). Progress towards non-peptide leads. Bioorganic & Medicinal Chemistry Letters. 3(5). 943–948. 6 indexed citations
11.
Dutta, Anand S., et al.. (1990). Antagonists of bombesin/gastrin releasing peptide based on [D-Ala24]GRP(20-26)-heptapeptide. Modifications leading to potent analogues with prolonged duration of action.. PubMed. 6(4). 255–71. 3 indexed citations
12.
Dutta, Anand S., et al.. (1990). Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp. Journal of Medicinal Chemistry. 33(9). 2552–2560. 8 indexed citations
13.
Dutta, Anand S., et al.. (1990). Inhibitors of human renin. Cyclic peptide analogs containing a D-Phe-Lys-D-Trp sequence. Journal of Medicinal Chemistry. 33(9). 2560–2568. 6 indexed citations
14.
Camble, Roger, et al.. (1990). Design and synthesis of bombesin/gastrin-releasing peptide antagonists. Biochemical Society Transactions. 18(6). 1294–1296. 1 indexed citations
15.
16.
Dutta, Anand S., et al.. (1989). Conformationally restrained cyclic peptides as antaconists of luteinizing hormone-releasing hormone. Biochemical and Biophysical Research Communications. 159(3). 1114–1120. 21 indexed citations
17.
18.
Dutta, Anand S., et al.. (1986). Antagonists of substance P. Further modifications of SP antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues. Journal of Medicinal Chemistry. 29(7). 1171–1178. 5 indexed citations
19.
Dutta, Anand S., B.J.A. Furr, Michael B. Giles, & J. S. Morley. (1976). SYNTHESIS AND BIOLOGICAL ACTIVITY OF α‐AZAPEPTIDES: α‐AZA‐ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE. Clinical Endocrinology. 5(s1). 291S–298S. 12 indexed citations
20.
Dutta, Anand S. & J. S. Morley. (1971). The preparation of o-benzyl-L-serine. Journal of the Chemical Society D Chemical Communications. 883a–883a. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Warren S. Wade Breakdown of academic impact, for papers by Ayumu Niida Breakdown of academic impact, for papers by A. J. Verkley Breakdown of academic impact, for papers by Theodore Lambros Breakdown of academic impact, for papers by Manas K. Chaudhuri Breakdown of academic impact, for papers by Francesco Chillemi Breakdown of academic impact, for papers by Sascha Hoogendoorn Breakdown of academic impact, for papers by Marie-Noëlle Dufour Breakdown of academic impact, for papers by Maria H. Knoppers Breakdown of academic impact, for papers by G. D. Clarke
Rankless by CCL
2026